FORMULATION OF PROPRANOLOL HYDROCHLORIDE ORALLY DISINTEGRATING TABLETS BY DIRECT COMPRESSION USING SIMPLEX LATTICE DESIGN

Main Article Content

Pienkit Dangprasirt

Abstract

Simple lattice experimental design was used to study the effects of three superdisintegrants; sodium starch glycolate (SG), crospovidone (Polyplasdone® XL, CP) and croscarmellose sodium (Ac-Di-Sol®, CS), on disintegration times of propranolol hydrochloride tablets intended to be prepared as orally disintegrating tablets. The contents of SG, CP and CS were varied according to the simplex lattice design resulting in seven tablet formulations. The PH tablets were prepared by direct compression using microcrystalline (Avicel® PH 102) and spray-dried lactose as diluents. Aspartame, magnesium stearate and talcum were used as sweetening agent, lubricant and glidant, respectively. The prepared tablets were tested for uniformity of weight, hardness, friability, disintegration time and dissolution. The equation representing the tablet disintegration time as function of SG, CP and CS ratios utilized in the tablet formulations was computed. A triangular contour plot of the predicted equation was also drawn. From the predicted equation and the contour plot, an optimum propranolol hydrochloride orally disintegrating tablet formulation yielding the predicted disintegration time of 2.98 seconds was selected. The propranolol hydrochloride orally disintegrating tablet, prepared according to the chosen formulation, provided the observed disintegration time of 3.08 seconds and met the USP drug dissolution requirement.

Article Details

How to Cite
1.
Dangprasirt P. FORMULATION OF PROPRANOLOL HYDROCHLORIDE ORALLY DISINTEGRATING TABLETS BY DIRECT COMPRESSION USING SIMPLEX LATTICE DESIGN. Interprof J Health Sci [Internet]. 2023 Oct. 5 [cited 2024 Dec. 6];13(2):39-46. Available from: https://li05.tci-thaijo.org/index.php/IJHS/article/view/119
Section
Research Articles

References

Battu SK, Repka MA, Majumdar S, Rao MY. 2007. Formulation and evaluation of rapidly disintegrating fenoverine tablets: Effect of superdisintegrants. Drug Dev. Ind. Pharm. 33:1225–1232.

Bolton S. 1986. Statistical applications in the pharmaceutical sciences. In: Lachman L, Liberman HA, Kanig JL editors. The theory and practice of industrial pharmacy. 3rd ed. Philadelphia: Lea&Febiger; pp. 283-285.

Botzolakis JE, Augsburger LL. 1988. Disintegrating agents in hard gelatin capsules. Part I: Mechanism of action, Drug Dev. Ind. Pharm. 14(1):29-41.

Hirani JJ, Rathod DA, Vadalla KR. 2009. Orally Disintegrating Tables: A Review. Trop. J. Pharm. Res. 8(2): 161-172.

Kumar GP, Nirmala. R. 2012. Fundamental aspects of superdisintegrants: a concise review. Journal of Global Pharma Technology. 4(02): 1-12.

Scheffe H. 1963. Simplex-centroid design for experiments with mixtures. J. R. Stat. Soc. B. 25: 235-263.

The Department of Health, Great Britain. The Department of Health, Social, Services and Public Safety, Northern Ireland. 2008. British Pharmacopoeia. Volume IV. London: The Stationary Office. Appendix XII C A313.

The United States Pharmacopeia. The National Formulary. 2009. USP 32 and NF 27. Volume 1.1. Volume 2.2. Rockville: The United States Pharmacopeial Convention.

U.S. Department of Health and Human Services. Food and Drug Administration. 2008. Guidance for Industry: Orally Disintegrating Tablets. Rockville: Center for Drug Evaluation and Research.